Ask Question
   Sign Guest book

Search Site
                                                        

 
About Lymphoma
| Advocacy | Art | CAM | Clinical trials 
Doctors and Centers | Guidelines at Diagnosis
Side Effects | Support | Symptoms
Tests | Treatments | Types of Lymphoma

Independent of industry funding, PAL depends on your support!

tax deductible

Patients Against Lymphoma

 

Find Trials By Type of Lymphoma and Treatment Status 
AND Related Conditions:
MDS, GVHD, Neuropathy

Also locate trials: by type of treatment agent AND Our Trials of Interest
 
Last update:
06/17/2013

In the News:

bullet
PTCL: CHOP Inadequate, but Comparison Clinical Trials Needed for Other Options  journals.lww.com   

See for trials for
 Untreated PTCL

Find Trials by Type of Lymphoma
and treatment status

click count as of Feb 2013: 3,861


 

Previously
Untreated
status
Clicks Relapsed
status
Clicks

Relapsed 
AND Not
Transplant

Clicks Other
(by request)

AIDS/HIV-related 

Untreated

> 7

Relapsed  > 9 Not Transplant  > 5

Relapsed & transplant  
>
10


Anaplastic Large Cell

Untreated

> 12

Relapsed

> 16

Not Transplant > 10 -


Burkitt's  

Untreated > 19 Relapsed

> 14

Not Transplant

> 11 -


Central Nervous System-related  

Untreated  > 62 Relapsed > 50 Not Transplant > 12 -


Childhood  (rare)

Untreated  > 6 Relapsed > 5 Not Transplant  > 6 -


Chronic Lymphocytic Leukemia  (CLL/SLL) 

Untreated  > 435
 
Relapsed > 147 Not Transplant > 31 -


Cutaneous (skin) lymphoma

Untreated  > 11 Relapsed > 4 Not Transplant  > 5 -


Diffuse Large B-Cell (DLBCL)

Untreated  

 

> 135

 

Relapsed > 148 Not Transplant

Transplant
> 98

> New

Autologous Transplant 
http://1.usa.gov/zKxJbW  
 
> 16


DLBCL, Alliance Trials

All Studies > New          


Epstein Barr Virus-related

Untreated  > 15 Relapsed > 5
 
Not Transplant > 6 -


Follicular b-cell

Untreated
 

 > 332 Relapsed > 242 Not Transplant > 82

Previously untreated and
NOT chemotherapy
 
>  25

 

Follicular,  Grade 3

 Untreated > NEW          

Follicular Alliance Trials

 All Studies            


Hodgkins 

Untreated > 126 Relapsed > 122 Not Transplant > 45 -

Nodular lymphocyte predominant HL (NLPHL)

 All Studies

> 13

- - - - -


Lymphoblastic, b or t cell

Untreated > 58

Relapsed

> 34 Not Transplant > 14 -


Mantle Cell  

Untreated > 78 Relapsed > 29 Not Transplant > 21 -


Marginal Zone / MALT  

Untreated > 111 Relapsed > 84 Not Transplant > 31 -


Ocular (eye) , b or t cell

Untreated > 13 Relapsed > 6 Not Transplant > 5 -


Primary Mediastinal B-cell  

Untreated > 44 Relapsed > 41 Not Transplant > 13 -


T-cell, all types

Untreated > 72 Relapsed > 21 Not Transplant > 10 -

Anaplastic Large Cell

Untreated > 6 Relapsed > 5      

Angioimmunoblastic

Untreated > 34 Relapsed > 19 Not Transplant > 5 -

Mycosis Fungoides OR
Sézary syndrome

Untreated > 9 Relapsed > 7 Not Transplant > 4 -

T-cell, Peripheral (PTCL)

Untreated > 90 Relapsed > 96 Not Transplant > 6 -


Transformed (from indolent)

Untreated > 28 Relapsed >
(> 42)
Not Transplant > 24 -

Transformed
(treated with radioimmunotherapy)

All studies > - - - - -


Waldenstrom's Macroglobulinemia  

Untreated > 71 Relapsed  >
(> 38)
Not Transplant > 11 -

Other: such as for treatment of complications of treatment

             


Graft versus Host disease (GVHD)

All trials
>
  acute
>
  chronic
>
  steroid refractory
>


Myelodysplastic Syndrome (MDS)

All trials > 4          


Chemotherapy-induced
peripheral neuropathy

All trials >   New & updated queries in yellow      

How to Use this Tool:

bullet

Locate your type of lymphoma, then click the query that best matches your treatment status.
 
The queries above are commands that locates studies in the ClinicalTrials.gov database.
 
A list of protocols will appear in a new ClinicalTrials.gov window.
 
bullet

TIP:  Click the Results on Map tab to find studies near you.
 

bullet

From the list of studies, click the protocol name to open it.

bullet

Review the Inclusion and Exclusion information to see if you are eligible to participate.

bullet

The protocol will often provide contact information. 

Feel free to contact investigators directly, but we feel that it's best to have the investigator and
your treating oncologist discuss the potential of the study to meet your clinical needs -- relative to other options.

bullet

If feasible:  Consult an independent Expert for the most objective information about what trials may be appropriate for you.

See Also:

bullet

How to inquire about trials

bullet

7 Reasons to Consider Clinical Trials: based on your clinical circumstances

bullet

Usage statistics for the queries above

 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.